Clinical intestinal transplantation: new perspectives and immunologic considerations.

PubWeight™: 2.31‹?› | Rank: Top 2%

🔗 View Article (PMC 2955329)

Published in J Am Coll Surg on May 01, 1998

Authors

K Abu-Elmagd1, J Reyes, S Todo, A Rao, R Lee, W Irish, H Furukawa, J Bueno, J McMichael, A T Fawzy, N Murase, J Demetris, J Rakela, J J Fung, T E Starzl

Author Affiliations

1: Thomas E. Starzl Transplantation Institute, University of Pittsburgh Medical Center, PA 15213, USA.

Articles citing this

Quality of life in patients receiving home parenteral nutrition. Gut (1999) 1.71

Immunomodulation for intestinal transplantation by allograft irradiation, adjunct donor bone marrow infusion, or both. Transplantation (2000) 1.53

Intestinal transplantation in children with chronic intestinal pseudo-obstruction. Gut (1999) 1.52

Clinical intestinal transplantation: a decade of experience at a single center. Ann Surg (2001) 1.44

The current status of small bowel transplantation in the UK and internationally. Gut (2005) 1.31

Intestinal transplantation under tacrolimus monotherapy after perioperative lymphoid depletion with rabbit anti-thymocyte globulin (thymoglobulin). Am J Transplant (2005) 0.95

Evolution of clinical intestinal transplantation: improved outcome and cost effectiveness. Transplant Proc (1999) 0.92

Short bowel syndrome: parenteral nutrition versus intestinal transplantation. Where are we today? Dig Dis Sci (2007) 0.92

Logistics and technique for procurement of intestinal, pancreatic, and hepatic grafts from the same donor. Ann Surg (2000) 0.84

The impact of positive T-cell lymphocytotoxic crossmatch on intestinal allograft rejection and survival. Transplant Proc (2000) 0.82

The efficacy of daclizumab for intestinal transplantation: preliminary report. Transplant Proc (2000) 0.82

Pancreatic transplantation at the University of Pittsburgh. Clin Transpl (2004) 0.81

Intestinal transplantation for patients with short gut syndrome and hypercoagulable states. Transplant Proc (2000) 0.78

Hepatic and intestinal transplantation at the University of Pittsburgh. Clin Transpl (1998) 0.78

Posttransplant lymphoproliferative disorders in small bowel allograft recipients. Transplant Proc (2000) 0.78

Modified technique for combined liver-small bowel transplantation in pigs. World J Gastroenterol (2003) 0.77

Clinical intestinal transplantation in 1998: Pittsburgh experience. Acta Gastroenterol Belg (1999) 0.77

The birth of clinical organ transplantation. J Am Coll Surg (2001) 0.76

Isolated intestinal versus composite visceral allografts: causes of graft failure. Transplant Proc (2000) 0.76

Small bowel transplant: an evidence-based analysis. Ont Health Technol Assess Ser (2003) 0.75

Recombinant HLA-G as Tolerogenic Immunomodulant in Experimental Small Bowel Transplantation. PLoS One (2016) 0.75

Multivisceral and small bowel transplantation at shiraz organ transplant center. Int J Organ Transplant Med (2014) 0.75

Auxiliary en-bloc liver-small bowel transplantation with partial pancreas preservation in pigs. World J Gastroenterol (2004) 0.75

The long-term efficacy of multivisceral transplantation. Transplant Proc (2000) 0.75

Imaging findings in children with proliferative disorders following multivisceral transplantation. Pediatr Radiol (2015) 0.75

Articles cited by this

Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep (1966) 48.83

FK 506 for liver, kidney, and pancreas transplantation. Lancet (1989) 13.70

Cell migration, chimerism, and graft acceptance. Lancet (1992) 12.24

Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology (1993) 8.76

THE REVERSAL OF REJECTION IN HUMAN RENAL HOMOGRAFTS WITH SUBSEQUENT DEVELOPMENT OF HOMOGRAFT TOLERANCE. Surg Gynecol Obstet (1963) 8.04

The many faces of multivisceral transplantation. Surg Gynecol Obstet (1991) 6.89

Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery (1991) 5.92

Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation. Lancet (1994) 5.54

Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01

Intestinal transplantation in composite visceral grafts or alone. Ann Surg (1992) 4.96

Successful small-bowel/liver transplantation. Lancet (1990) 4.85

Systemic chimerism in human female recipients of male livers. Lancet (1992) 3.63

Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation (1995) 3.63

Transplantation of multiple abdominal viscera. JAMA (1989) 3.59

Chimerism after liver transplantation for type IV glycogen storage disease and type 1 Gaucher's disease. N Engl J Med (1993) 3.36

Immunobiology of tissue transplantation: a return to the passenger leukocyte concept. Annu Rev Immunol (1983) 3.32

Outcome analysis of 71 clinical intestinal transplantations. Ann Surg (1995) 2.95

The lost chord: microchimerism and allograft survival. Immunol Today (1996) 2.81

The use of FK-506 for small intestine allotransplantation. Inhibition of acute rejection and prevention of fatal graft-versus-host disease. Transplantation (1990) 2.79

Management of intestinal transplantation in humans. Transplant Proc (1992) 2.62

Three years clinical experience with intestinal transplantation. J Am Coll Surg (1994) 2.20

Hamster-to-rat heart and liver xenotransplantation with FK506 plus antiproliferative drugs. Transplantation (1993) 2.17

Induction of liver, heart, and multivisceral graft acceptance with a short course of FK 506. Transplant Proc (1990) 2.15

Graft-versus-host disease after brown Norway-to-Lewis and Lewis-to-Brown Norway rat intestinal transplantation under FK506. Transplantation (1993) 2.14

Pathology of human intestinal transplantation. Gastroenterology (1996) 1.98

Lymphocyte traffic and graft-versus-host disease after fully allogeneic small bowel transplantation. Transplant Proc (1991) 1.89

Logistics and technique for combined hepatic-intestinal retrieval. Ann Surg (1992) 1.85

Activation of transplant immunity: effect of donor leukocytes on thyroid allograft rejection. Science (1976) 1.80

Prolongation of murine islet allograft survival by pretreatment of islets with antibody directed to Ia determinants. Proc Natl Acad Sci U S A (1981) 1.77

Small intestinal transplantation in humans with or without the colon. Transplantation (1994) 1.74

Successful orthotopic small bowel transplantation with short-term FK 506 immunosuppressive therapy. Transplant Proc (1990) 1.71

Successful small bowel transplantation in an infant. Transplantation (1992) 1.69

Piggyback orthotopic intestinal transplantation. Surg Gynecol Obstet (1993) 1.55

Studies in small bowel transplantation. Prevention of graft-versus-host disease with preservation of allograft function by donor pretreatment with antilymphocyte serum. Transplantation (1988) 1.52

Multivisceral intestinal transplantation: surgical pathology. Pediatr Pathol (1989) 1.45

Current results of intestinal transplantation. The International Intestinal Transplant Registry. Lancet (1996) 1.39

Abdominal multivisceral transplantation. Transplantation (1995) 1.37

Spontaneous and iatrogenically augmented leukocyte chimerism in organ transplant recipients. Transplant Proc (1994) 1.29

Current status of intestinal transplantation in children. J Pediatr Surg (1998) 1.28

Augmentation of chimerism in whole organ recipients by simultaneous infusion of donor bone marrow cells. Transplant Proc (1995) 1.24

Successful small intestine transplantation. Transplant Proc (1992) 1.17

Successful multivisceral transplantation. Transplant Proc (1992) 1.09

Graft-versus-host disease after liver and small bowel transplantation in a child. Clin Transplant (1997) 1.09

Nutritional management of intestinal transplant recipients. Transplant Proc (1993) 1.09

The influence of donor and recipient strains in isolated small bowel transplantation in rats. Transplant Proc (1994) 1.04

Immunohistochemical demonstration of enteric nervous distribution after syngeneic small bowel transplantation in rats. Surgery (1995) 0.97

Successful clinical small-bowel transplantation. Transplant Proc (1990) 0.96

Effect of pretransplant graft irradiation on canine intestinal transplantation. Surg Gynecol Obstet (1988) 0.95

Fine quantitation by competitive PCR of circulating donor cells in posttransplant chimeric recipients. Transplantation (1994) 0.95

Cytomegalovirus infection after intestinal transplantation in children. Clin Infect Dis (1997) 0.93

Prevention of graft-versus-host disease following small bowel transplantation with polyclonal and monoclonal antilymphocyte serum. The effect of timing and route of administration. Transplantation (1991) 0.90

Augmentation of natural chimerism with donor bone marrow in orthotopic liver recipients. Transplant Proc (1996) 0.90

Endorectal pull-through of transplanted colon as part of intestinal transplantation. Surgery (1995) 0.88

Recipient preconditioning and donor-specific bone marrow infusion in a pig model of total bowel transplantation. Transplantation (1997) 0.83

Tacrolimus analysis: a comparison of different methods and matrices. Ther Drug Monit (1995) 0.83

Articles by these authors

Evolution of liver transplantation. Hepatology (1982) 19.54

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell (1997) 15.96

FK 506 for liver, kidney, and pancreas transplantation. Lancet (1989) 13.70

Cell migration, chimerism, and graft acceptance. Lancet (1992) 12.24

IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science (1997) 11.89

A flexible procedure for multiple cadaveric organ procurement. Surg Gynecol Obstet (1984) 10.33

Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology (1993) 8.76

Bone marrow as a potential source of hepatic oval cells. Science (1999) 8.52

Orthotopic liver transplantation in ninety-three patients. Surg Gynecol Obstet (1976) 8.11

The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet (1980) 7.40

The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet (1967) 7.24

Fifteen years of clinical liver transplantation. Gastroenterology (1979) 7.19

Venous bypass in clinical liver transplantation. Ann Surg (1984) 7.04

Liver transplantation with use of cyclosporin a and prednisone. N Engl J Med (1981) 6.95

The many faces of multivisceral transplantation. Surg Gynecol Obstet (1991) 6.89

The portal circulation: I. The action of adrenaline and pituitary pressor extract. J Physiol (1932) 6.88

Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial. Lancet (1999) 6.69

Orthotopic homotransplantation of the human liver. Ann Surg (1968) 6.64

Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence. Science (1999) 6.37

Guided medication dosing for inpatients with renal insufficiency. JAMA (2001) 6.25

Vascular homografts from cadaveric organ donors. Surg Gynecol Obstet (1979) 6.23

Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery (1991) 5.92

Abdominal organ cluster transplantation for the treatment of upper abdominal malignancies. Ann Surg (1989) 5.78

Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) (1988) 5.77

Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74

Refinements in the surgical technique of liver transplantation. Semin Liver Dis (1985) 5.70

Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction. Transplant Proc (1974) 5.53

Extended survival in 3 cases of orthotopic homotransplantation of the human liver. Surgery (1968) 5.44

Modulation of chromatin structure regulates cytokine gene expression during T cell differentiation. Immunity (1998) 5.38

Cyclophosphamide and whole organ transplantation in human beings. Surg Gynecol Obstet (1971) 5.24

Alternative methods of arterialization of the hepatic graft. Surg Gynecol Obstet (1984) 5.16

Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction. Surgery (1988) 5.03

Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01

Intestinal transplantation in composite visceral grafts or alone. Ann Surg (1992) 4.96

Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc (1990) 4.90

Pancreaticoduodenal transplantation in humans. Surg Gynecol Obstet (1984) 4.49

Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology (1994) 4.32

A simplified technique for revascularization of homografts of the liver with a variant right hepatic artery from the superior mesenteric artery. Surg Gynecol Obstet (1985) 4.29

Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation. Immunol Today (1993) 4.29

The T-cell transcription factor NFATp is a substrate for calcineurin and interacts with Fos and Jun. Nature (1993) 4.26

Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine. Transplant Proc (1987) 4.21

Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A. Science (1999) 4.20

Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet (1990) 4.18

Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery (1994) 4.16

Facial fractures and submental tracheal intubation. Anaesthesia (2002) 4.13

Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg (1989) 4.12

Malignant lymphomas in transplantation patients. Transplant Proc (1969) 4.12

Gene regulation mediated by calcium signals in T lymphocytes. Nat Immunol (2001) 4.09

Role of liver transplantation in cancer therapy. Ann Surg (1985) 4.08

Biliary complications after liver transplantation: with special reference to the biliary cast syndrome and techniques of secondary duct repair. Surgery (1977) 4.08

Shwartzman reaction after human renal homotransplantation. N Engl J Med (1968) 4.05

The Australian Incident Monitoring Study. Crisis management--validation of an algorithm by analysis of 2000 incident reports. Anaesth Intensive Care (1993) 4.04

A 21-year experience with major hemorrhage after percutaneous liver biopsy. Gastroenterology (1990) 4.02

Baboon-to-human liver transplantation. Lancet (1993) 4.01

Extended preservation of human liver grafts with UW solution. JAMA (1989) 3.99

Canine and human liver preservation for 6 to 18 hr by cold infusion. Transplantation (1977) 3.99

Liver transplantation in the United States, 1999-2008. Am J Transplant (2010) 3.92

Clinical presentation of hepatic artery thrombosis after liver transplantation in the cyclosporine era. Transplantation (1985) 3.91

The preparation and testing of horse antidog and antihuman antilymphoid plasma or serum and its protein fractions. Surg Gynecol Obstet (1967) 3.86

Replacement of donor lymphoid tissue in small-bowel transplants. Lancet (1991) 3.85

The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood. Surg Gynecol Obstet (1973) 3.84

Partners in transcription: NFAT and AP-1. Oncogene (2001) 3.83

Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs. Lancet (1976) 3.74

Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A. Transplant Proc (1987) 3.73

Structure of the DNA-binding domains from NFAT, Fos and Jun bound specifically to DNA. Nature (1998) 3.71

Hepatic trisegmentectomy and other liver resections. Surg Gynecol Obstet (1975) 3.66

Right trisegmentectomy for hepatic neoplasms. Surg Gynecol Obstet (1980) 3.64

Systemic chimerism in human female recipients of male livers. Lancet (1992) 3.63

Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation (1995) 3.63

Antitumor agents. 203. Carbazole alkaloid murrayaquinone A and related synthetic carbazolequinones as cytotoxic agents. J Nat Prod (2000) 3.62

Hepatic Retransplantation. Transplant Proc (1985) 3.62

Transplantation of multiple abdominal viscera. JAMA (1989) 3.59

Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg (1991) 3.57

An STS-based radiation hybrid map of the human genome. Genome Res (1997) 3.57

Canine liver transplantation under Nva2-cyclosporine versus cyclosporine. Transplantation (1986) 3.54

Combination donor hepatectomy and nephrectomy and early functional results of allografts. Surg Gynecol Obstet (1982) 3.49

Long-term survival after renal transplantation in humans: (with special reference to histocompatibility matching, thymectomy, homograft glomerulonephritis, heterologous ALG , AND RECIPIENT MALIGNANCY). Ann Surg (1970) 3.48

IN VITRO IMMUNOSUPPRESSIVE EFFECTS OF FR 900506 ON HUMAN T LYMPHOCYTE ALLOACTIVATION. Surg Res Commun (1987) 3.46